WELLINGTON MANAGEMENT GROUP LLP - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$64,837,000
-34.2%
7,746,382
-28.8%
0.01%
-36.4%
Q3 2019$98,491,000
-17.2%
10,883,082
-1.4%
0.02%
-15.4%
Q2 2019$118,901,000
+188.9%
11,039,985
+155.9%
0.03%
+188.9%
Q1 2019$41,150,000
+75.0%
4,313,453
+110.5%
0.01%
+50.0%
Q4 2018$23,520,000
+18.7%
2,048,725
+75.2%
0.01%
+50.0%
Q3 2018$19,817,000
+814.5%
1,169,218
+666.3%
0.00%
Q2 2018$2,167,000
-35.2%
152,574
-13.3%
0.00%
-100.0%
Q1 2018$3,344,000
+53.9%
176,017
+32.8%
0.00%
Q4 2017$2,173,000
+339.0%
132,502
+55.0%
0.00%
Q2 2016$495,000
-37.4%
85,500
-34.6%
0.00%
Q1 2016$791,000
-66.1%
130,700
-68.4%
0.00%
-100.0%
Q3 2015$2,334,000
-48.9%
413,720
+0.5%
0.00%0.0%
Q2 2015$4,565,000
-28.1%
411,580
+1.6%
0.00%
-50.0%
Q1 2015$6,351,000
+5.6%
405,040
+2.4%
0.00%0.0%
Q4 2014$6,014,000
+24.4%
395,380
-11.8%
0.00%
+100.0%
Q3 2014$4,836,000
-21.8%
448,480
+10.7%
0.00%
-50.0%
Q2 2014$6,186,000
+1067.2%
405,120
+497.5%
0.00%
Q2 2013$530,00067,8000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders